Stock Research for ELGX


Featured Broker: Ally Invest

Get the due diligence for another stock.


ELGX Stock Chart & Research Data

The ELGX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ELGX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


ELGX Due diligence Resources & Stock Charts

The ELGX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ELGX Detailed Price Forecast - CNN Money CNN View ELGX Detailed Summary - Google Finance
Yahoo View ELGX Detailed Summary - Yahoo! Finance Zacks View ELGX Stock Research & Analysis -

Stock Analysis

TradeIdeas View ELGX Trends & Analysis - Trade-Ideas Barrons View ELGX Major Holders - Barrons
NASDAQ View ELGX Call Transcripts - NASDAQ Seeking View ELGX Breaking News & Analysis - Seeking Alpha
Spotlight View ELGX Annual Report - OTC Report View ELGX OTC Short Report -
TradeKing View ELGX Fundamentals - TradeKing Charts View ELGX SEC Filings - Bar Chart
WSJ View Historical Prices for ELGX - The WSJ Morningstar View Performance/Total Return for ELGX - Morningstar
MarketWatch View the Analyst Estimates for ELGX - MarketWatch CNBC View the Earnings History for ELGX - CNBC
StockMarketWatch View the ELGX Earnings - StockMarketWatch MacroAxis View ELGX Buy or Sell Recommendations - MacroAxis
Bullish View the ELGX Bullish Patterns - American Bulls Short Pains View ELGX Short Pain Metrics -

Social Media Mentions

StockTwits View ELGX Stock Mentions - StockTwits PennyStocks View ELGX Stock Mentions - PennyStockTweets
Twitter View ELGX Stock Mentions - Twitter Invest Hub View ELGX Investment Forum News - Investor Hub
Yahoo View ELGX Stock Mentions - Yahoo! Message Board Seeking Alpha View ELGX Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for ELGX - Insider Cow View Insider Transactions for ELGX - Insider Cow
CNBC View ELGX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ELGX - OTC Markets
Yahoo View Insider Transactions for ELGX - Yahoo! Finance NASDAQ View Institutional Holdings for ELGX - NASDAQ

Stock Charts

FinViz View ELGX Stock Insight & Charts - StockCharts View ELGX Investment Charts -
BarChart View ELGX Stock Overview & Charts - BarChart Trading View View ELGX User Generated Charts - Trading View

Latest Financial News for ELGX

Endologix, Inc. to Announce Third Quarter 2018 Financial Results on November 1, 2018
Posted on Monday October 22, 2018

Endologix, Inc. (ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it will report financial results for the third quarter of fiscal year 2018 after the market close on Thursday, November 1, 2018. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. This conference call will also be webcast and can be accessed from the “Investors” section of the Company’s website at

Consolidated Research: 2018 Summary Expectations for Barnes & Noble, Boot Barn, Endologix, Pilgrim's Pride, OraSure Technologies, and Genesco — Fundamental Analysis, Key Performance Indications
Posted on Thursday October 18, 2018

NEW YORK, Oct. 18, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

FDA Classifies Previous Endologix AFX Safety Notice as Class I Recall
Posted on Friday October 05, 2018

Endologix® Inc. (ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today that it has received notice that the U.S. Food and Drug Administration (FDA) has classified a voluntary recall action that Endologix took in July of this year as a Class I recall. The July recall involved Endologix’s issuance of a Safety Notice to healthcare professionals (HCPs) using the AFX® Endovascular AAA System. The Safety Notice, dated 20 July 2018, provided updated information on comparative AFX Type III endoleak rates, patient-tailored surveillance recommendations, and recommendations for intervening through an AFX device or re-intervening on an AFX device.

The Daily Biotech Pulse: Endologix's Q3 Sales, Obseva's Positive Trial Results, Kala To Offer Shares
Posted on Wednesday October 03, 2018

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting 52-week highs on Oct. 1) Boston Scientific Corporation (NYSE: BSX ) Eli Lilly ...

Stock Market & Investing Books

Enter a stock symbol to view the stock details.